In 2006, Novartis committed $755 million in corporate citizenship initiatives around the world, particularly focusing on improved access to medicines in the developing world.
 

The Novartis Foundation for Sustainable Development is a charitable foundation that works at policy and field level to improve access to healthcare for the world’s poorest people.  It is one of many Novartis Foundations worldwide which also include scientific and research foundations, as well as venture capital and social foundations.

• Donations of medicines to patients affected by leprosy (4 million patients cured since 2000)
• Donations of medicines to patients affected by tuberculosis (donations of medication reaching 500,000 patients)
• Malaria treatment at cost in many parts of Asia, Africa and Latin America
• Glivec patient assistance programmes around the world to help ensure access for patients who cannot afford the drug
• Relief to support major humanitarian organisations with emergency medical needs ($14 million committed in 2005)

The Novartis Institute for Tropical Diseases in Singapore is run to discover novel treatments and prevention methods for major tropical diseases, such as tuberculosis and dengue fever, to make them available without profit. 

The Novartis Biotechnology Leadership Camp (BioCamp) is a pioneering three-day seminar that brings the biotechnology sector closer to talented young people from universities across the world. BioCamp has been sponsored annually by several Novartis affiliates since 2004, and in 2007, the first European BioCamp was held in Switzerland. This year's European BioCamp will take place on August 28-30, 2008, at the Novartis Campus in Basel, Switzerland.
 

At the seminar, 40 selected students  will have the opportunity to learn from leading biotech experts, interact with professionals and work together with other students from various cultures. The students also will be able to explore career opportunities and network with global leaders in the biotechnology sector. Two students from the European BioCamp will be selected to participate at the global Novartis BioCamp on October 24-27, 2008, in Hong Kong.
Novartis will cover all travel and accommodation expenses of the chosen students. The event will be held in English.
 

BioCamp is open to graduate students in the natural sciences. The students must be proficient in English. Applicants must be enrolled at a UK university. Admission to BioCamp is based on academic excellence and professional experience. Successful students will be notified in June.

This deadline has now passed and no more applications are being accepted.